Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jan 28, 2005; 11(4): 538-544
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.538
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.538
Table 3 Dry weight/wet weight ratio of pancreas and serum amylase (action of PACAP) (mean±SE).
| Group | Pancreatic dry weight/wet weight ratio (%) | Serum amylase (IU/L) |
| Normal control | 29.21±5.657 | 520.8±163.27 |
| Caerulein-induced pancreatitis | 21.83±3.013a | 3699.33±3826.56a |
| Sodium taurocholate-induced pancreatitis | 17.52±1.505a | 3690.87±2277.99a |
| PACAP 5 μg | 25.86±1.974 | 818.09±404.76a |
| PACAP 10 μg | 24.81±1.312 | 675.55±271.44 |
| PACAP 15 μg | 23.88±2.532 | 671.36±151.98a |
| PACAP 30 μg | 25.17±0.897 | 899.09±474.49 |
| Sodium taurocholate+PACAP 5 μg | 19.18±2.102a | 2944.33±1182.47a |
| Sodium taurocholate+PACAP 10 μg | 20.87±5.597a | 1986.91±710.97a |
| Caerulein+PACAP 15 μg | 17.66±4.652a | 4053.55±2164.07a |
| Caerulein+PACAP 30 μg | 13.45±2.045a | 5243.46±3769.73a |
- Citation: Chen YD, Zhou ZG, Wang Z, Gao HK, Yan WW, Wang C, Zhao GP, Peng XH. Pituitary adenylate cyclase activating-peptide and its receptor antagonists in development of acute pancreatitis in rats. World J Gastroenterol 2005; 11(4): 538-544
- URL: https://www.wjgnet.com/1007-9327/full/v11/i4/538.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i4.538